Posts in tag

substitution


Supply is improving for tocilizumab (Actemra) products but disruptions to some products will continue beyond this month, warns Roche Availability of tocilizumab (Actemra) products is “improving” and supply should be …

Pharmacists now able to substitute alternatives for menopause treatment after a scarcity notification was issued    The Therapeutic Goods Administration (TGA) has advised of a shortage of all strengths of …

Community pharmacists are now able to substitute Actemra formulations without prior prescriber approval, due to serious shortages Two tocilizumab (Actemra) formulations are now effectively interchangeable at the pharmacy level after …

Pharmacy has a prominent role in the supply and provision of biosimilar medicines, and the profession has been slow to come to terms with this. Is the situation now changing? …

Mixed views over medicine substitution by pharmacists as Parliament debates TGA amendment bill There have been divergences of opinions expressed in Federal Parliament about the substitution of medicines by pharmacists …

Thousands of pharmacy and other retail jobs at risk from Jobseeker cuts as businesses and employees are set to suffer financially, MPs tell Parliament Federal parliamentarians have debated the impact …

Government releases details on proposed pharmacist medicine substitution process, but concerns are raised that it’s “too complex, too slow” The Therapeutic Goods Administration (TGA) has released details on the Federal …

During the COVID-19 pandemic, the general public badly needs certainty around access to medicines, says one pharmacy leader Following the postponement of the Pharmacy Guild’s flagship Australian Pharmacy Professional Conference …

Some pharmacists feel that they can make generic substitutions or changes to instructions where this is unauthorised, thinking these actions have no consequence – but that’s not the case In …

Pharmacists’ authority to use their expertise to substitute one medicine for another should also apply to biological medicines, says FIP The International Pharmaceutical Federation has published a revised Statement of …

The Consumers Health Forum has expressed its concerns about the issue of substitution of biological medicines with biosimilars, at a meeting called by the Pharmaceutical Benefits Advisory Committee. CEO of …